Significant increase of prostaglandin E-Major urinary metabolite in male smokers: A screening study of age and gender differences using a simple radioimmunoassay

Journal of Clinical Laboratory Analysis

Volumn 28, Issue 1, 2014, Pages 32-41

  Okayasu, Isao ^a   Ohnishi, Hiromitsu ^b   Sarandi, Istvan ^c   Shojima, Junko ^d   Komatsu, Junko ^d   Oritsu, Masae ^d   Sasabe, Masataka ^e   Nanami, Kaori Okayasu ^f   Matsuura, Masaaki ^g   Azumi, Jun ichi ^h   Ito, Satoru ^h   Fujiwara, Mutsunori ^d  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TFB Inc   (Japan)

^c Institute of Isotopes   (Hungary)

^d JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^e Kudanzaka Hospital   (Japan)

^f Social Insurance Chuo General Hospital   (Japan)

^g CANCER INSTITUTE   (Japan)

^h FUJIREBIO INC   (Japan)

Author keywords

Age and gender; CRP; Prostaglandin E major urinary metabolite; Radioimmunoassay; Smoking

Indexed keywords

C REACTIVE PROTEIN; CREATININE; PROSTAGLANDIN E; PROSTAGLANDIN E MAJOR URINARY METABOLITE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DRINKING BEHAVIOR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL EXAMINATION; MIDDLE AGED; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCREENING; SEX DIFFERENCE; SMOKING; URINALYSIS;

AGE AND GENDER; CRP; PROSTAGLANDIN E-MAJOR URINARY METABOLITE; RADIOIMMUNOASSAY; SMOKING;

ADULT; AGE FACTORS; C-REACTIVE PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRINKING BEHAVIOR; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTAGLANDINS E; RADIOIMMUNOASSAY; RADIOISOTOPE DILUTION TECHNIQUE; REPRODUCIBILITY OF RESULTS; SEX CHARACTERISTICS; SMOKING;

EID: 84892471421     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21640     Document Type: Article

References (31)

1. Thun MJ, Namboodiri MM, Heath CW, Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-1596.
2. DuBois RN, Smalley WE. Cyclooxygenase, NSAIDs, and colorectal cancer. J Gastroenterol 1996;31:898-906.
3. Inagawa T, Imaki K, Masuda H, et al. Simplified immunoassays of prostaglandin E main metabolite in human urine. Adv Prostaglandin Thromboxane Leukot Res 1983;11:191-196.
4. Fujiwara M, Okayasu I, Oritsu M, et al. Significant increase in prostaglandin E-main urinary metabolite by laxative administration: Comparison with ulcerative colitis. Digestion 2000;61:201-206.
5. 2 synthesis in healthy humans and those with lung cancer. Anal Biochem 2004;334:26-75.
6. Gross ND, Boyle JO, Morrow JD, et al. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clin Cancer Res 2005;11:6087-6093.
7. Duffield-Lillico AJ, Boyle JO, Zhou XK, et al. Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: Evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila) 2009;2:322-329.
8. Ferreira SH, Vane JR. Prostaglandins: Their disappearance from and release into the circulation. Nature 1967;216:868-873.
9. Uppal S, Diggle CP, Carr IM, et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertyrophic osteoartheropathy. Nat Genet 2008;40:789-793.
10. Yao B, Xu J, Harris RC, Zhang M-Z. Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenase. Am J Physiol Renal Physiol 2008;294:F433-F439.
11. Razmara A, Krause DN, Duckles SP. Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats. Am J Physiol Heart Circ Physiol 2005;289:H1843-H1850.
12. Miyagi M, Morishita M, Iwamoto Y. Effects of sex hormones on production of prostaglandin E2 by human peripheral monocytes. J Periodontol 1993;64:1075-1078.
13. Morishita M, Miyagi M, Iwamoto Y. Effects of sex hormones on production of interleukin-1 by human peripheral monocytes. J Periodontol 1999;70:757-760.
14. Dienstknecht T, Schwacha MG, Kang SC, et al. Sex steroid-mediated regulation of macrophage/monocyte function in a two-hit model of trauma-hemorrhage and sepsis. Cytokine 2004;25:110-118.
15. Vegeto E, Bonincontro C, Pollio G, et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001;21:1809-1818.
16. Ganesan K, Balachandran C, Manohar BM, et al. Comparative studies on the interplay of testosterone, estrogen and progesterone in collagen induced arthritis in rats. Bone 2008;43:758-765.
17. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007;317:121-124.
18. Nakagawa H, Maeda S, Yoshida H, et al. Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences. Int J Cancer 2009;125:2264-2269.
19. Lu B, Jiang YJ, Choy PC. 17-Beta estradiol enhances prostaglandin E2 production in human U937-derived macrophages. Mol Cell Biochem 2004;262:101-110.
20. ElAttar TM. Prostaglandin E2 in human gingiva in health and disease and its stimulation by female sex steroids. Prostaglandins 1976;11:331-341.
21. Frasor J, Weaver AE, Pradhan M, et al. Synergistic up-regulation of prostaglandin E synthase expression in breast cancer cells by 17beta-estradiol and proinflammatory cytokines. Endocrinology 2008;149:6272-6279.
22. Buist AV, Vollmer WM. Smoking and other risk factors. In: Murray JE, Nadel JA (Eds.), Textbook of Respiratory Medicine. WB Saunders, Philadelphia, PA, 1994. p 1259-1287.
23. Snider GL. Chronic obstructive pulmonary disease: Risk factors, pathophysiology and pathogenesis. Annu Rev Med 1989;40:411-429.
24. Chen Y, Chen P, Hanaoka M, et al. Enhanced levels of prostaglandin E2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 2008;13:1014-1021.
25. Szulakowski P, Crowther AJ, Jimenez LA, et al. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:41-50.
26. Profita M, Sala A, Bonanno A, et al. Chronic obstructive pulmonary disease andneutrophil infiltration: Role of cigarette smoke and cyclooxygenase products. Am J Physiol Lung Cell Mol Physiol 2010;298:L261-L269.
27. Ballou SP, Lozanski FB, Hodder S, et al. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing 1996;25:224-230.
28. Yamada S, Gotoh T, Nakashima Y, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001;153:1183-1190.
29. Ito Y, Suzuki K, Tamakoshi K, et al. Colorectal cancer and serum C-reactive protein levels: A case-control study nested in the JACC Study. J Epidemiol 2005;15(Suppl 2):S185-S189.
30. Dohi Y, Takase H, Sato K, et al. Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects. Int J Cardiol 2007;115:63-66.
31. Hegener HH, Diehl KA, Kurth T, et al. Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: A nested case-control approach. J Thromb Haemost 2006;4:1718-1722.